These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 682365

  • 41. Studies on improvement of pharmaceutical preparations prescribed in hospitals. IV. Dibekacin sulfate viscous solution for treatment of mouth and throat wounds.
    Namiki N, Yokoyama H, Moriya K, Fukuda M, Takashima T, Uchida Y, Yuasa H, Kanaya Y.
    Drug Des Deliv; 1986 Nov; 1(2):157-65. PubMed ID: 3509329
    [Abstract] [Full Text] [Related]

  • 42. Rapid method for determination of kanamycin and dibekacin in serum by use of high-pressure liquid chromatography.
    Kubo H, Kobayashi Y, Nishikawa T.
    Antimicrob Agents Chemother; 1985 Oct; 28(4):521-3. PubMed ID: 4073874
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Nucleic acid synthesis in the developing mouse ovary, uterus and oviduct studied by light and electron microscopic radioautography.
    Li SF, Nagata T.
    Cell Mol Biol (Noisy-le-grand); 1995 Feb; 41(1):185-95. PubMed ID: 7539655
    [Abstract] [Full Text] [Related]

  • 46. [Absorption and excretion of cefotaxime and its levels in uterine arterial blood, female internal genital organ tissue and pelvic cavity fluid (author's transl)].
    Saito Y, Kushima T, Seimori T, Narita J, Taguchi K, Shitara Y, Ohtomo K, Gotoh K, Takeuchi Y, Taguchi J.
    Jpn J Antibiot; 1981 Apr; 34(4):481-8. PubMed ID: 6270395
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Animal experiments on the nephrotoxicity, pharmacokinetics and therapeutic efficacy of dibekacin].
    Bopp S, Marre R, Schulz E, Sack K.
    Arzneimittelforschung; 1981 Apr; 31(3):473-7. PubMed ID: 7194672
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [The effect of dibekacin in the treatment of external ocular infections, with special reference to the pseudomonas infection of the eye (author's transl)].
    Tokuda H, Amano R, Matsuda H, Nejime K, Tazawa Y, Shimada K, Uchida Y, Yamanishi R, Kotera K.
    Nippon Ganka Gakkai Zasshi; 1981 Dec 10; 85(12):2126-37. PubMed ID: 7342734
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Substrate-labeled fluorescent immunoassay for measuring dibekacin concentrations in serum and plasma.
    Place JD, Thompson SG.
    Antimicrob Agents Chemother; 1983 Aug 10; 24(2):240-5. PubMed ID: 6357071
    [Abstract] [Full Text] [Related]

  • 54. [Pharmacokinetics of dibekacin in patients with chronic renal impairment].
    Viotte G, Leroy A, Godin M, Fillastre JP.
    Nouv Presse Med; 1982 Nov 18; 11(46):3414-8. PubMed ID: 7155849
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Immunologic analysis of dibekacin in human serum: comparison of 4 methods].
    Lesne M, Mebsout F, Jacqmin P.
    J Pharm Belg; 1983 Nov 18; 38(2):69-75. PubMed ID: 6875794
    [No Abstract] [Full Text] [Related]

  • 58. [Comparative study on intravenous drip infusion of dibekacin once daily and twice daily in treatment of complicated urinary tract infections].
    Kishi H, Kaneco H, Tominaga T, Niijima T, Nishimura Y, Saito I, Ishii Y, Nito H, Yuge J, Asano M.
    Hinyokika Kiyo; 1984 Jan 18; 30(1):103-20. PubMed ID: 6375317
    [Abstract] [Full Text] [Related]

  • 59. [Neuromuscular blocking properties of tobramycin, dibekacin and ribostamycin in man (author's transl)].
    Arai T, Hashimoto Y, Shima T, Matsukawa S, Iwatsuki KI.
    Jpn J Antibiot; 1977 Apr 18; 30(4):281-4. PubMed ID: 864858
    [Abstract] [Full Text] [Related]

  • 60. Quantitative determination of dibekacin using radioimmunoassay, substrate-labelled fluorescent immunoassay and rate nephelometric inhibition immunoassay for tobramycin.
    Duriez D, Dewilde A, Marzin D, Wattré P.
    Ann Inst Pasteur Microbiol (1985); 1985 Apr 18; 136A(3):381-8. PubMed ID: 3901881
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.